Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis
Open accessThe DOI matches its Crossref record; 319 of the 333 references it cites were found in a registry or an index.
Abstract
Human T lymphotropic viruses (HTLVs) are complex deltaretroviruses that do not contain a proto-oncogene in their genome, yet are capable of transforming primary T lymphocytes both in vitro and in vivo. There are four known strains of HTLV including HTLV type 1 (HTLV-1), HTLV-2, HTLV-3 and HTLV-4. HTLV-1 is primarily associated with adult T cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV-2 is rarely pathogenic and is sporadically associated with neurological disorders. There have been no diseases associated with HTLV-3 or HTLV-4 to date. Due to the difference in the disease manifestation between HTLV-1 and HTLV-2, a clear understanding of their individual pathobiologies and the role of various viral proteins in transformation should provide insights into better prognosis and prevention strategies. In this review, we aim to summarize the data accumulated so far in the transformation and pathogenesis of HTLV-1, focusing on the viral Tax and HBZ and citing appropriate comparisons to HTLV-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Tomita, M., Semenza, G. L., Michiels, C., Matsuda, T., Uchihara, J.-N., Okudaira, T., Tanaka, Y., Taira, N., Ohshiro, K., & Mori, N. (2007) · Biochemical Journal · doi:10.1042/bj20070286 · Cited by 46 · cited 2×
“Mechanistically, Tax frees a catalytic p110 subunit of the PI3K complex from an inhibitory p85 subunit by binding directly to the latter [256]; Tax induces the RelA-mediated sequestration of p300 from the promoters of phosphatase and tensin homolog (PTEN) and SH2 domain-containing inositol phosphatase - 1 (SHIP-1),…”
BackgroundRetractedHuman T-Cell Leukemia Virus Type 1 Tax Dysregulates β-CateninSignaling
Tomita, M., Kikuchi, A., Akiyama, T., Tanaka, Y., & Mori, N. (2006) · Journal of Virology · doi:10.1128/jvi.00739-06 · Cited by 36
RetractedFukuda, R.-I., Tsuchiya, K., Suzuki, K. A. O., Itoh, K., Fujita, J., Utsunomiya, A., & Tsuji, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806325200 · Cited by 21
RetractedPoiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043 · cited 2×
“HTLV-1 was originally identified in 1980 in a T cell line derived from a patient with cutaneous T cell lymphoma [1] and was also detected in adult T cell leukemia (ATL) patients [2,3].”
BackgroundPhosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766 · cited 1×
“enhancer [204,205,207].”
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Regulation and Function of NF-κB Transcription Factors in the Immune System
Vallabhapurapu, S., & Karin, M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132641 · Cited by 2,588 · cited 2×
“(p50/p105) and NF-B2 (p52/p100) [204-206].”
BackgroundHTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY
Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M., & Tara, M. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91298-5 · Cited by 2,404 · cited 1×
“On the contrary, for HAM/TSP, disease progression can typically occur within a few years of infection [94,98].”
BackgroundIntegrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K. I., Shirakawa, S., & Miyoshi, I. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6476 · Cited by 2,252
Research works printed but not linked: 2
- 50. Matsumoto M, Nomuta K, Matsumoto T, Nishioka K, Harada S, Forusho H, Kikuchi H, Kato Y, Utsonomiya A, Uematsu T, Iwahashi M, Hashimoto S, Yunoki K. Adult T-cell leukemia-lymphoma in Kagoshima District, southwestern Japan: Clinical and hematological characteristics. Jpn J Clin Oncol. 1979;9:325–336.
- 157. Murata N, Hakoda E, Machida H, Ikezoe T, Sawada T, Hoshino H, Miyoshi I. Prevention of HTLV-1 infection in Japanese macaques by passive immunization. Leukemia. 1996;10:1971–1974.
Cited by
Items 101–139 of 139
Santos, T. A. P., Rocha, A. S., Lopes-Ribeiro, Á., Corrêa-Dias, L. C., Melo-Oliveira, P., Reis, E. V. D. S., da Fonseca, F. G., Barbosa‐Stancioli, E. F., Tsuji, M., & Coelho-dos-Reis, J. G. A. (2023) · Biomolecules · doi:10.3390/biom13030545 · Cited by 2
Rybicki, E. P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822784-8.00005-2 · Cited by 1
Evaluation of CLOCK and CSNK1D Function in Circadian Rhythm Signaling Pathways in HTLV-1 Carriers
Ekhtiari, M., Bastan, F., Rashidian, M., Safavi, M., Yaslianifard, S., Ashrafi, J., Kermanian, F., & Mozhgani, S. (2023) · Future Virology · doi:10.2217/fvl-2023-0050 · Cited by 1
Intercellular Transport of Viral Proteins
Simon, F., & Thoma‐Kress, A. K. (2024) · Results and problems in cell differentiation · doi:10.1007/978-3-031-62036-2_18 · Cited by 1
Lavorgna, A., & Harhaj, E. W. (2013) · Future Virology · doi:10.2217/fvl.13.1 · Cited by 1
Yamashiro, J. A. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2014.tde-02062014-114612 · Cited by 1
Human T-Cell Lymphotropic Virus (HTLV-1) and Adult T-Cell Leukemia
Mohammad, R., & Gholami, M. (2011) · InTech eBooks · doi:10.5772/23517
“Although research data indicate that Tax, among all the viral proteins, is the viral oncoprotein, but emerging data suggests a supporting role for HBZ in the oncogenic process (Kannian 2010).”
BackgroundInfluentialLeal, F. E. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2012.tde-10092012-160323 · Cited by 1
Pleiotropic Functions of HTLV-1 Tax Contribute to Cellular Transformation
Pryor, K., & Susan, J. (2013) · InTech eBooks · doi:10.5772/54787 · Cited by 3
Semeão, L. E. D. S. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2015.tde-20052015-115430
“(1) Existem, até o momento, quatro subtipos conhecidos de HTLV, dentre os quais os mais importantes nos quesitos patogenia e epidemiologia são o HTLV I e II.”
BackgroundMolecular analysis of HTLV-2 APH-2 in viral transformation, persistence and host immune response
Yin, H. (2011) · OhioLink ETD Center (Ohio Library and Information Network)
[Report of a case of strongyloidiasis with a coinfection by HTLV-1 and onychomycosis].
Álvarez-Falconí, P. P., Moncada-Vilela, Z., Montero-Navarrete, S., & Hernandez-García, J. A. (2013) · PubMed
Human T-cell Leukemia Virus Type I (HTLV-I) Retropepsin
Nguyen, J., & Kiso, Y. (2012) · Handbook of Proteolytic Enzymes · doi:10.1016/b978-0-12-382219-2.00049-1
Ferreira, M. C. M. R. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2017.tde-10012017-095656
dos Santos, D. F. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2019.tde-22112018-081731
Evolution of simianretroviruses
Ayouba, A., & Peeters, M. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139794749.011
Cann, A. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384939-7.10005-5
Cann, A. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801946-7.00005-5
Raca, G., van der Krogt, J., Beau, M. M. L., & Włodarska, I. (2014) · Springer eBooks · doi:10.1007/978-3-642-39590-1_2
Nesterova, A. P., Климов, Е. А., Zharkova, M. S., Sozin, S., Sobolev, V., Ivanikova, N. V., Shkrob, M., & Yuryev, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817086-1.00002-6
Louten, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90565-7.00009-5
Mahdifar, M., Akbari-Eidgahi, M. R., Mosavat, A., Pourreza, A., Akbarin, M. M., Valizadeh, N., Sarbaz, M., Kiani, B., Rezaee, S. A., & Rafatpanah, H. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4180497
Current status of viral biomarkers for oncogenic viruses
Arğa, K. Y., & Kori, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824156-1.00009-1 · Cited by 3
Nicolela, N. C. S. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.60.2022.tde-02032023-141856
Blanco, G., Tapias, Z., & Viñoles, F. C. (2023) · Revista Digital de Postgrado · doi:10.37910/rdp.2023.12.1.e355
Human Cancer Viruses: Molecular Mechanisms of OncogenesisPreprint
Damian, D., Maghembe, R. S., & Damas, M. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4588149
Oncogenic virus associated with human cancer: A review
Ali, M. A., Abdullahi, S., Gambo, S., & Khaleel, Z. I. (2022) · International journal of oncology research. · doi:10.33545/2664665x.2022.v2.i1a.8
Ma, N., Bose, D., & Robertson, E. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00114-5
Immunopathogenesis of HAM/TSP and Radiological Features of Disease Progression
Stack, E. H., Mina, Y., Nair, G., & Jacobson, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_26
Singh, S., & Yadav, P. (2026) · Molecular Biotechnology · doi:10.1007/s12033-026-01561-6
“The viral Tax protein is a potent trans activator that plays a central role in onco-genesis by activating transcription factors, such as NF-κB, CREB, and AP-1, leading to increased cell proliferation and resistance to apoptosis [76, 77].”
Impact of oncogenic viruses on autoimmune diseases and tumorigenesis
Sofiani, V. H., Mahani, F. K., Farsiu, N., Yousefi, M., Naderi, M., Ahmadi, G., & Nakhaie, M. (2026) · Infectious Agents and Cancer · doi:10.1186/s13027-026-00746-7 · Cited by 1
“The virus has developed strategies to evade the immune system, including downregulation of major histocompatibility complex (MHC) molecules and inhibition of apoptosis in infected T-cells [128].”
Découverte et caractérisation de la protéine APH-2 codée par le brin antisens du HTLV-2
Douceron, E. (2011) · theses.fr (ABES) · doi:10.70675/ccbc3046zcdc4z4076za386zc9a56cedbf0a
Turpin, J. (2014) · theses.fr (ABES) · doi:10.70675/cc9adef4za010z4e4bzbc54z5e5fedfb7d43
Famille des Marseilleviridae : étude de la pathogénicité potentielle et description du pan-génome
Aherfi, S. (2016) · theses.fr (ABES) · doi:10.70675/80ff15cdz3aa8z4e50zbd61z9ca9bf1bfc92
Human T-lymphotropic viruses types 1 and 2 in the 21st century (A systematic review)
Апанович, П. В., Алексеевна, Д. Э., & Акимкин, В. Г. (2026) · Journal Infectology · doi:10.22625/2072-6732-2026-18-2-5-16
Sena, M. D. A., Neto, G. D. S. P., Azevedo, E. D. A. N., Reis, C. R. D. S., & de Morais, C. N. L. (2026) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2026.117714
Metadata
- Authors
- Kannian, P., & Green, P. L.
- Affiliations
- The Ohio State University (US)
- Corresponding author
- Green, Patrick L.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2010-09-24
- Volume
- 2
- Issue
- 9
- Pages
- 2037-2077
- ISSN
- 1999-4915 (ISSN-L)
- PMC
- PMC3185741
- OpenAlex
- W2040466820
- Cited by
- 139
- References
- 333
- Citations by year
- 2026: 9 · 2025: 1 · 2024: 9 · 2023: 15 · 2022: 9 · 2021: 9 · 2020: 3 · 2019: 7 · 2018: 9 · 2017: 9 · 2016: 9 · 2015: 11 · 2014: 9 · 2013: 10 · 2012: 12
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Viruses (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Keywords
- HTLV-1, T-cell transformation, carcinogenesis, adult T-cell leukemia/lymphoma, HTLV-1-associated myelopathy/tropical spastic paraparesis, HTLV-II, viral pathogenesis, viral proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.